AU2003303074A1 - Sphingolipid derivatives modified by polyethylene glycol and composition containing the same - Google Patents
Sphingolipid derivatives modified by polyethylene glycol and composition containing the sameInfo
- Publication number
- AU2003303074A1 AU2003303074A1 AU2003303074A AU2003303074A AU2003303074A1 AU 2003303074 A1 AU2003303074 A1 AU 2003303074A1 AU 2003303074 A AU2003303074 A AU 2003303074A AU 2003303074 A AU2003303074 A AU 2003303074A AU 2003303074 A1 AU2003303074 A1 AU 2003303074A1
- Authority
- AU
- Australia
- Prior art keywords
- same
- polyethylene glycol
- composition containing
- derivatives modified
- sphingolipid derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/20—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a carbon atom of an acyclic unsaturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/32—Polymers modified by chemical after-treatment
- C08G65/329—Polymers modified by chemical after-treatment with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6905—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion
- A61K47/6911—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion the form being a liposome
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dispersion Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR10-2002-0079663 | 2002-12-13 | ||
| KR1020020079663A KR20040051958A (en) | 2002-12-13 | 2002-12-13 | Sphingolipid derivatives modified by polyethylene glycol and composition containing the same |
| PCT/KR2003/002716 WO2004054963A1 (en) | 2002-12-13 | 2003-12-11 | Sphingolipid derivatives modified by polyethylene glycol and composition containing the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2003303074A1 true AU2003303074A1 (en) | 2004-07-09 |
Family
ID=32588789
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003303074A Abandoned AU2003303074A1 (en) | 2002-12-13 | 2003-12-11 | Sphingolipid derivatives modified by polyethylene glycol and composition containing the same |
Country Status (3)
| Country | Link |
|---|---|
| KR (1) | KR20040051958A (en) |
| AU (1) | AU2003303074A1 (en) |
| WO (1) | WO2004054963A1 (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20050051862A (en) * | 2003-11-28 | 2005-06-02 | 주식회사 두산 | Sphingolipid-peg derivatives and composition for skin external use containing the derivatives |
| KR100736145B1 (en) * | 2004-06-01 | 2007-07-06 | 주식회사 두산 | Monomethylpytosphingosine-polyethylene glycol and anticancer composition containing same |
| WO2006080589A1 (en) * | 2004-12-21 | 2006-08-03 | Doosan Corporation | Sphingolipid-peg derivatives and composition for skin external use containing the derivatives |
| WO2009076598A1 (en) | 2007-12-12 | 2009-06-18 | Children's Hospital & Research Center At Oakland | Use of unsaturated sphingosine compounds as chemotherapeutic agents for the treatment of cancer |
| US20090187060A1 (en) * | 2008-01-22 | 2009-07-23 | E-Z-Em, Inc. | Method and Formulation for Neutralizing Toxic Chemicals and Materials |
| KR102423002B1 (en) * | 2021-02-17 | 2022-07-21 | 주식회사 엘씨에스바이오텍 | New ceramide, method for preparing the new ceramide and its use |
| CN119174825B (en) * | 2024-09-23 | 2025-07-04 | 西南大学 | Amphotericin B nano-composite based on sphingosine coupling polyethylene glycol carrier and preparation method and application thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5225212A (en) * | 1989-10-20 | 1993-07-06 | Liposome Technology, Inc. | Microreservoir liposome composition and method |
| US5820873A (en) * | 1994-09-30 | 1998-10-13 | The University Of British Columbia | Polyethylene glycol modified ceramide lipids and liposome uses thereof |
-
2002
- 2002-12-13 KR KR1020020079663A patent/KR20040051958A/en not_active Ceased
-
2003
- 2003-12-11 AU AU2003303074A patent/AU2003303074A1/en not_active Abandoned
- 2003-12-11 WO PCT/KR2003/002716 patent/WO2004054963A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004054963A1 (en) | 2004-07-01 |
| KR20040051958A (en) | 2004-06-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003227480A1 (en) | Modified polymers and compositions containing the same | |
| IL166129A0 (en) | Pyrrolotriazine derivatives and pharmaceutical compositions containing the same | |
| AU2003275719A1 (en) | Deodorant composition | |
| IL162548A0 (en) | 4-Oxoquinoline derivatives and pharmaceutical compositions containing the same | |
| AU2003254898A1 (en) | Fragrance composition | |
| AU2002306269A1 (en) | N-arylphenylacetamide derivatives and pharmaceutical composition containing the same | |
| AU2003291103A1 (en) | Pharmaceutical composition | |
| AU2003275620A1 (en) | Capsule type hardener and composition | |
| AU2003296188A1 (en) | Radiation-sensitive resin composition | |
| AU2003284401A1 (en) | Cosmetic composition | |
| AU2002367625A1 (en) | Radiation-sensitive resin composition | |
| AU2003285288A1 (en) | Composition | |
| AU2003280797A1 (en) | Shampoo composition | |
| AU2003289440A1 (en) | Nitrogen-containing heterocycic derivatives, medicinal compositions containing the same and medicinal use thereof | |
| AU2003227263A1 (en) | Phosphor and phosphor composition containing the same | |
| AU2003302315A1 (en) | Desulfurization and novel compositions for same | |
| AU2003256805A1 (en) | Compounds compositions and methods | |
| AU2003250372A1 (en) | Pharmaceutical composition | |
| IL165775A0 (en) | Novel quinuclidine derivatives and medicinal compositions containing the same | |
| AU2002950744A0 (en) | Composition | |
| AU2003289187A1 (en) | Perfluoroallyloxy compound and liquid-crystal composition containing the compound | |
| AU2003276710A1 (en) | Deodorant composition | |
| AU2003235708A1 (en) | Polytartrate composition | |
| EP1400571A3 (en) | Aerosol composition | |
| EP1422263B8 (en) | Resin composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |